CI Stock Recent News
CI LATEST HEADLINES
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Cigna (CI) closed at $348.78 in the latest trading session, marking a +0.78% move from the prior day.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Cigna Group is one of the few companies that have outperformed the AI-fantasy-driven S&P 500 Index by a wide margin. After a 50% return in less than a year and a new all-time high, it's fair to ask whether it's wise to sell Cigna stock now. In this update, I share my view on Cigna's performance in 2023 and explain why I decided to hold on to my Cigna shares - despite the historically expensive valuation.
Investors with an interest in Medical - HMOs stocks have likely encountered both Cigna (CI) and Humana (HUM). But which of these two stocks is more attractive to value investors?
The recent uptick in U.S. manufacturing signals a promising trend for the economy. Investor confidence in the economy's stability is reflected in the decreasing odds for a June rate cut, indicating optimism about future monetary policy.
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.